Big in Japan: Israel’s has partnered with four Japanese companies

The four companies operate in the healthcare, insurance, and network infrastructure industries

James Spiro 16:3312.08.20
Israeli medical technology startup has partnered with four different Japanese companies, all announced this week. NTT Data, Alm (MySOS), Macnica Networks, and Sompo will all adopt its technology and tools in different ways. has developed a Vital Signs Monitoring Tool which can be applied on any device equipped with a camera using signal processing and artificial intelligence. Its solution can be used as a health and wellness monitoring solution and removes the need for wearables when measuring heart rate, mental stress, blood pressure, or breathing rate.

David Maman, Founder, and CEO of Photo: David Maman, Founder, and CEO of Photo:


NTT Data adopts Binah’ai’s technology to capture face data for the Health Data Bank. Using non-contact vital data acquisition technology, the information provided by NTT Data will try to solve the problems of industrial health post-Covid-19 for more than 400,000 people by 2022.


Alm’s MySOS will use’s non-contact vital sign measurement technology to provide information to medical institutions during an emergency. It will also be able to monitor suspected infection rates among new Covid-19 patients.


Macnica Networks provides security measures and solutions for networks all over Japan. Using, it will use the solution for its customers and contribute to the realization of “prevention and reinfection spread and economic activity” during the Covid-19 pandemic.


Finally, SOMPO, which is part of Himawari Life Insurance, will offer an app to allow insurance policyholders to perform health checkups via their smartphones. Using’s solution, customers will be able to record a short video of their faces, and the app will analyze stress levels and the risk of lifestyle-related diseases. The free service will be used by 90,000 people in its first year.

“We’re proud to continue developing, and creating Collaborations with advanced companies all over the world,” said David Maman, Founder, and CEO of “We see great success with the Japanese market that is strategic for us. We’re thrilled with every success we achieve in this very demanding and high-standard market and looking forward to keep growing and reaching more markets worldwide.” was founded in 2016 by Maman, Michael Markzon, and Konstantin Gadlin. To date, it has raised $14.5 million by notable investors such as Maverick. Its offices are located in Ramat Gan, Israel.